Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies

NCT01662284 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT01662284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01662284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies
Lead sponsor
University of Wisconsin, Madison
Phase
Observational
Overall status
Terminated
Start date
July 31, 2012
Completion date
May 31, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast, prostate, colorectal, gastric, ovarian, pancreatic, esophageal, soft tissue sarcoma, and head & neck cancer